
ArsenalBiorevenue & acquisition
South San Francisco, CaliforniaFounded 2019
ArsenalBio was acquired.
ArsenalBio was founded with the mission to discover, develop, and commercialize curative immune cell therapies for solid tumors.
ArsenalBio revenue
ArsenalBio has not published its revenue. Growjo puts it at about $72.4M a year (December 2023).
| As of | Revenue | Source |
|---|---|---|
| Dec 2023 | $72.4MEST | Growjo estimate |
Who owns ArsenalBio
Another company owns ArsenalBio. The date and price of the deal are not on record.
ArsenalBio CEO, founders & employees
Ken Drazan founded ArsenalBio in 2019 and led it as CEO. ArsenalBio had 327 employees (December 2023, Growjo estimate).
- Ken DrazanFounder & CEO
All 2 headcount readings, with sources
| As of | Employees | Source |
|---|---|---|
| Dec 2023 | 327EST | Growjo estimate |
| Dec 2022 | 268EST | Growjo estimate |
ArsenalBio FAQ
What was ArsenalBio's revenue?
Growjo estimates ArsenalBio's revenue at about $72.4M a year (December 2023). The company hasn't published its own figure.
How many employees does ArsenalBio have?
Growjo estimates ArsenalBio's headcount at about 327 (December 2023).
Who founded ArsenalBio?
Ken Drazan founded ArsenalBio in 2019.
Categories
How this page is sourced
3 estimates. Founder figures link to the second they were said; public figures name their source; estimates are marked EST and say whose they are. Not financial advice.
Updated Oct 5, 2026Data disclaimerReport a correctionClaim this profileRun ArsenalBio? Join the podcast